It is likely that the complex repertoire of somatic and germ-line genomic anomalies complement each other and what amounts to a driver event depends on the constellation of passenger events that are also present in the cancer genome. The purpose of PrediGO is to help to resolve the network of these anomalies by identifying biological process level abnormalities in individual cancers based on combined analysis of gene expression, DNA copy number and mutation profiling results.

PrediGO was created by the PREDICT consotria and was launched end of 2013.

Click the logo to start navigate to the site.

Leave a Comment

No Comments Yet!